| Kenalog Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Kenalog 0.1% | ointment | topical | 100.0 gram(s) | OTC |
| Kenalog 0.147 mg/g | spray | topical | 1.0 gram(s) | OTC |
| Kenalog 0.1% | lotion | topical | 100.0 milliliter(s) | OTC |
| Kenalog 0.025% | lotion | topical | 100.0 milliliter(s) | OTC |
| Kenalog 0.1% | cream | topical | 100.0 gram(s) | OTC |
| Kenalog 0.025% | cream | topical | 100.0 gram(s) | OTC |
| Kenalog 0.5% | cream | topical | 100.0 gram(s) | OTC |
Posted by shirlytemple about 22 hours ago
I had a kenalog shot a year and a half ago and over time my purple hole on my hip/but area was just getting bigger and bigger...
Posted by dltfr 9 days ago
Kenalog destroyed my life! All corticosteroids are dangerous. Almost 4 years now of intolerable suffering. A doctor gave m...
Posted by cyhadd 14 days ago
I am freaking out reading all of this. My dermatologist just injected my scalp about 20 times with Kenalog for female pattern...
Endophthalmitis rates low in ongoing intravitreal steroid trials - OSN SuperSite (subscription)
In pooled data from seven other studies involving 3248 patients treated with intravitreal injections of Kenalog (triamcinolone, Bristol-Meyers Squibb), ...
Fri Jan 25 14:12:43 -0500 2008
Advice: Dr. Donohue - NorthJersey.com
He sent me to an ear, nose and throat doctor, who said the white patches look like lichen planus, and he has me on Kenalog in Orabase. ...
Fri Dec 14 09:56:01 -0500 2007
The FDA Raises Safety Concerns Regarding Off-Label Use of Avastin ... - StreetInsider.com (subscription)
... Therapeutics Drugs Mentioned: - Aflibercept (VEGF Trap) - Avastin (bevacizumab) - Herceptin (trastuzumab) - Kenalog/Kenacort (triamcinolone acetonide, ...
Wed Jan 02 13:37:48 -0500 2008
triamcinolone acetonide - The acetonide salt form of triamcinolone, a synthetic glucocorticosteroid with immunosuppressive and anti-inflammatory activity. Triamcinolone acetonide binds to specific cytosolic glucocorticoid receptors and subsequently interacts with glucocorticoid receptor response element on DNA and alters gene expression. This results in an induction of the synthesis of certain anti-inflammatory proteins while inhibiting the synthesis of certain inflammatory mediators. Consequently, an overall reduction in chronic inflammation and autoimmune reactions are accomplished.